Research Article
Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke
Table 3
Independent predictors of death within 3 months after stroke.
| | Predictors | Alive | Died | Unadjusted OR (95% CI) | value | Adjusted OR (95% CI) | value |
| | Age > 45 years | 306 (63.9) | 173 (18.9) | 1.527 (0.84–2.635) | 0.127 | 0.984 (0.451–2.147) | 0.967 | | Male gender | 206 (66.7) | 103 (33.3) | 0.856 (0.602–1.216) | 0.384 | — | — | | HTN | 343 (65.1) | 184 (34.9) | 1.013 (0.443–2.318) | 0.975 | — | — | | DM | 111 (57.2) | 83 (42.8) | 1.693 (1.178–2.432) | 0.004 | 0.984 (0.506–1.913) | 0.961 | | Smoking | 70 (76.7) | 21 (23.1) | 0.506 (0.300–0.853) | 0.010 | 0.839 (0.372–1.895) | 0.673 | | Alcohol | 151 (70.9) | 62 (29.1) | 0.665 (0.454–0.946) | 0.024 | 0.768 (0.417–1.412) | 0.395 | | Dyslipidemia | 285 (68.8) | 129 (31.2) | 0.530 (0.358–0.786) | 0.001 | 0.602 (0.305–1.187) | 0.143 | | Obesity | 113 (71.1) | 46 (28.9) | 0.684 (0.459–1.019) | 0.061 | 0.429 (0.103–1.778) | 0.243 | | METS | 93 (69.9) | 40 (30.1) | 0.751 (0.492–1.143) | 0.180 | 1.705 (0.359–8.103) | 0.502 | | CAD/IHD | 23 (67.6) | 11 (32.4) | 0885 (0.422–1.858) | 0.748 | — | — | | AFIB | 34 (49.3) | 35 (50.7) | 2.124 (1.275–3.533) | 0.003 | 3.198 (1.386–7.376) | 0.006 | | Cardiopathy | 36 (52.9) | 32 (47.1) | 1.789 (1.072–2.986) | 0.025 | 1.129 (0.483–2.642) | 0.779 | | Valvulopathy | 20 (66.7) | 10 (33.3) | 0.929 (0.426–2.027) | 0.853 | — | — | | Previous stroke | 71 (62.3) | 43 (37.7) | 1.167 (0.761–1.788) | 0.479 | — | — | | CKD | 17 (43.7) | 22 (56.4) | 2.596 (1.343–5.017) | 0.003 | 2.139 (0.829–5.522) | 0.116 | | Hemorrhagic stroke | 104 (53.1) | 92 (46.9) | 2.242(1.560–3.223) | <0.001 | 1.211 (0.635–2.307) | 0.561 | | SBP > 140 mmHg | 276 (63.6) | 158 (36.4) | 1.574 (0.885–2.134) | 0.156 | 1.751 (0.803–3.821) | 0.159 | | DBP > 90 mmHg | 227 (62.4) | 137 (37.6) | 1.867 (1.225–2.854) | 0.061 | 0.801 (0.405–1.586) | 0.525 | | Hyperglycemia | 107 (52.2) | 98 (47.8) | 2.439 (1.699–3.502) | <0.001 | 2.263 (1.203–4.256) | 0.011 | | High LDLc | 270 (66.0) | 139 (34.0) | 0.858 (0.578–1.273) | 0.447 | — | — | | Low HDLc | 210 (70.9) | 86 (24.7) | 0.574 (0.403–0.817) | 0.002 | 0.673 (0.394–1.148) | 0.146 | | High TC | 170 (62.7) | 101 (37.3) | 1.227 (0.865–1.741) | 0.252 | — | — | | High TG | 70 (51.1) | 67 (48.9) | 2.203 (1.484–3.270) | <0.001 | 1.857 (1.003–3.437) | 0.049 | | Hyperuricemia | 148 (56.5) | 114 (40.7) | 2.067 (1.449–2.950) | <0.001 | 1.265 (0.707–2.263) | 0.428 | | GCS ≤ 8 | 8 (8.7) | 84 (91.3) | 33.908(15.916–72.242) | <0.001 | 7.604 (3.221–17.948) | <0.001 | | NIHSS > 14 | 60 (27.6) | 157 (72.4) | 21.806(13.820–34.407) | <0.001 | 6.733 (3.659–12.390) | <0.001 | | mRS > 2 | 184 (50.0) | 184 (50.0) | 19.556(9.708–39.392) | <0.001 | 3.363 (1.456–7.767) | 0.005 | | Complications | 108 (46.6) | 124 (53.4) | 4.193 (2.894–6.075) | <0.001 | 1.631 (0.943–2.821) | 0.080 |
|
|
METS: metabolic syndrome; AFIB: atrial fibrillation; CKD: chronic kidney disease; CAD/IHD: coronary artery/ischemic heart disease.
|
